Marc-Redwart Kok (Marc R Kok)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 28

Top Topics

Rheumatoid Arthritis

Radical Prostatectomy

Disease Activity

Top Venues

Annals of the rheumatic diseases

Arthritis care & research

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Selinde V J Snoeck Henkemans, Pascal Hendrik Pieter de Jong, Jolanda J Luime, Marc-Redwart Kok, Ilja Tchetverikov, Lindy-Anne Korswagen, Sjoerd M van der Kooij, Maikel van Oosterhout, Paul Baudoin, Jessica Bijsterbosch, Jos H van der Kaap, Annette H M van der Helm van Mil, Marijn Vis
Window of opportunity in psoriatic arthritis: the earlier the better? RMD open 10 (1) (2024)
Selinde V J Snoeck Henkemans, Pascal Hendrik Pieter de Jong, Jolanda J Luime, Marc-Redwart Kok, Ilja Tchetverikov, Lindy-Anne Korswagen, Sjoerd M van der Kooij, Maikel van Oosterhout, Paul Baudoin, Jessica Bijsterbosch, Jos H van der Kaap, Annette H M van der Helm van Mil, Marijn Vis
Window of opportunity in psoriatic arthritis: the earlier the better? RMD open 10 (1) (2024)
Gonul Hazal Koc, Marc-Redwart Kok, Yvandra do Rosario, Jolanda J Luime, Ilja Tchetverikov, Fazira R Kasiem, Lindy-Anne Korswagen, Jessica Bijsterbosch, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Paul Baudoin, Petra Kok, Radboud J E M Dolhain, Marijn Vis
Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort. RMD open 10 (2) (2024)
Nathan den Broeder, Lise Verhoef, Yaël A de Man, Marc-Redwart Kok, Rogier Thurlings, Wilfred van der Weele, Bart Jf van den Bemt, Frank Hj van den Hoogen, Aatke van der Maas, Alfons A den Broeder
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial. RMD open 10 (2) (2024)
Nathan den Broeder, Lise Verhoef, Yaël A de Man, Marc-Redwart Kok, Rogier Thurlings, Wilfred van der Weele, Bart Jf van den Bemt, Frank Hj van den Hoogen, Aatke van der Maas, Alfons A den Broeder
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial. RMD open 10 (2) (2024)
Gonul Hazal Koc, Marc-Redwart Kok, Yvandra do Rosario, Jolanda J Luime, Ilja Tchetverikov, Fazira R Kasiem, Lindy-Anne Korswagen, Jessica Bijsterbosch, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Paul Baudoin, Petra Kok, Radboud J E M Dolhain, Marijn Vis
Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort. RMD open 10 (2) (2024)
Selinde V J Snoeck Henkemans, Pascal Hendrik Pieter de Jong, Jolanda J Luime, Marc-Redwart Kok, Ilja Tchetverikov, Lindy-Anne Korswagen, Sjoerd M van der Kooij, Maikel van Oosterhout, Paul Baudoin, Jessica Bijsterbosch, Jos H van der Kaap, Annette H M van der Helm van Mil, Marijn Vis
Window of opportunity in psoriatic arthritis: the earlier the better? RMD open 10 (1) (2024)
Nathan den Broeder, Lise Verhoef, Yaël A de Man, Marc-Redwart Kok, Rogier Thurlings, Wilfred van der Weele, Bart Jf van den Bemt, Frank Hj van den Hoogen, Aatke van der Maas, Alfons A den Broeder
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial. RMD open 10 (2) (2024)
Shannon A Gunawardana, Philip S Helliwell, Marc-Redwart Kok, Marijn Vis, Andrew Allard, Akpabio Akpabio, Aallaa Alsaffar, Jessica C Ellis, Fazira R Kasiem, Rachel Macmillan, Ben Mulhearn, Aine Gorman, Laura C Coates, William Tillett
The Development and Validation of a Novel Training Infographic for the Physician Global Visual Analog Scale in Psoriatic Arthritis. The Journal of rheumatology (2024)
Nathan den Broeder, Lise Verhoef, Yaël A de Man, Marc-Redwart Kok, Rogier Thurlings, Wilfred van der Weele, Bart Jf van den Bemt, Frank Hj van den Hoogen, Aatke van der Maas, Alfons A den Broeder
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial. RMD open 10 (2) (2024)
Gonul Hazal Koc, Marc-Redwart Kok, Yvandra do Rosario, Jolanda J Luime, Ilja Tchetverikov, Fazira R Kasiem, Lindy-Anne Korswagen, Jessica Bijsterbosch, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Paul Baudoin, Petra Kok, Radboud J E M Dolhain, Marijn Vis
Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort. RMD open 10 (2) (2024)
Fiona Koster, Marc-Redwart Kok, Jaco van der Kooij, Geeke Waverijn, Angelique Elisabeth Adriana Maria Weel, Deirisa Lopes Barreto
Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing. PharmacoEconomics - open (2023)
Fiona Koster, Pieter L H Bakx, Marc-Redwart Kok, Deirisa Lopes Barreto, Angelique Elisabeth Adriana Maria Weel
Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison. Rheumatology international (2023)
Selinde V J Snoeck Henkemans, Pascal Hendrik Pieter de Jong, Jolanda J Luime, Marc-Redwart Kok, Ilja Tchetverikov, Fazira R Kasiem, Sarah Welby, Adam R Prickett, Annette H M van der Helm van Mil, Marijn Vis, null null
Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritis. RMD open 8 (2) (2023)
Fazira R Kasiem, Marc-Redwart Kok, Jolanda J Luime, Ilja Tchetverikov, Lindy-Anne Korswagen, Natasja H A M Denissen, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili, Johanna M W Hazes, William Tillett, Marijn Vis, null null
Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis. RMD open 9 (4) (2023)
Melek Güler-Yüksel, Martijn Kuijper, Reinhard Bos, Esmeralda Molenaar, Jasper Emmering, Sylvia Eshuis, Adams Human, Floor Reimann, Maarten Boers, Marc-Redwart Kok
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. RMD open 9 (2) (2023)
Fiona Koster, Marc-Redwart Kok, Jaco van der Kooij, Geeke Waverijn, Angelique Elisabeth Adriana Maria Weel, Deirisa Lopes Barreto
Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing. PharmacoEconomics - open (2023)
Selinde V J Snoeck Henkemans, Pascal Hendrik Pieter de Jong, Jolanda J Luime, Marc-Redwart Kok, Ilja Tchetverikov, Fazira R Kasiem, Sarah Welby, Adam R Prickett, Annette H M van der Helm van Mil, Marijn Vis, null null
Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritis. RMD open 8 (2) (2023)
Melek Güler-Yüksel, Martijn Kuijper, Reinhard Bos, Esmeralda Molenaar, Jasper Emmering, Sylvia Eshuis, Adams Human, Floor Reimann, Maarten Boers, Marc-Redwart Kok
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. RMD open 9 (2) (2023)
Selinde V J Snoeck Henkemans, Pascal Hendrik Pieter de Jong, Jolanda J Luime, Marc-Redwart Kok, Ilja Tchetverikov, Fazira R Kasiem, Sarah Welby, Adam R Prickett, Annette H M van der Helm van Mil, Marijn Vis, null null
Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritis. RMD open 8 (2) (2023)
Fiona Koster, Marc-Redwart Kok, Deirisa Lopes Barreto, Angelique E A M Weel-Koenders
Capturing Patient Value in an Economic Evaluation. Arthritis care & research (2023)
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem F Lems, Yvo Smulders, Maurizio Cutolo, Marieke M Ter Wee
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the rheumatic diseases (2023)
Marijke van den Dikkenberg, Nathalie Luurssen-Masurel, Tjallingius Martijn Kuijper, Marc-Redwart Kok, Johanna Maria Wilhelmina Hazes, Pascal Hendrik Pieter de Jong, Deirisa Lopes-Barreto, Angelique Elisabeth Adriana Maria Weel-Koenders
Meta-analyses on the effects of Disease Modifying Anti-Rheumatic Drugs on the most relevant Patient-Reported Outcome domains in Rheumatoid Arthritis. Arthritis care & research (2022)
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Eduard N Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, L Thomas Klausch, Sabrina Paolino, Annemarie M Schilder, Willem F Lems, Maurizio Cutolo, null null
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the rheumatic diseases 81 (7) (2022)
Fazira R Kasiem, Annelieke Pasma, Jolanda J Luime, Ilja Tchetverikov, Kim Wervers, Lindy-Anne Korswagen, Natasja Denissen, Yvonne P M Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili, Johanna M W Hazes, Martijn Bastiaan Adriaan van Doorn, Marc-Redwart Kok, Marijn Vis, null null
A Practical Guide for Assessment of Skin Burden in Patients With Psoriatic Arthritis. The Journal of rheumatology 49 (10) (2022)
Luis Fernando Perez-Garcia, Esther Röder, Robbert J Goekoop, Johanna M W Hazes, Marc-Redwart Kok, Hieronymus T W Smeele, Ilja Tchetverikov, Annette H M van der Helm van Mil, Jos H van der Kaap, Petra Kok, Bouwe P Krijthe, Radboud J E M Dolhain
Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility). Annals of the rheumatic diseases 80 (12) (2021)
Hannah den Braanker, Astrid C van Stigt, Marc-Redwart Kok, Erik Lubberts, Radjesh J Bisoendial
Single-Cell RNA Sequencing Reveals Heterogeneity and Functional Diversity of Lymphatic Endothelial Cells. International journal of molecular sciences 22 (21) (2021)
Mark Matthijs Bakker, Polina Putrik, Jany Rademakers, Mart van de Laar, Harald E Vonkeman, Marc-Redwart Kok, Hanneke Voorneveld-Nieuwenhuis, Josef S Smolen, Maarten P T de Wit, Rachelle Buchbinder, Roy Batterham, Richard H Osborne, Annelies Boonen
Addressing Health Literacy Needs in Rheumatology: Which Patient Health Literacy Profiles Need the Attention of Health Professionals? Arthritis care & research 73 (1) (2021)